-
Worth Watching Stocks: Verizon Communications Inc. (NYSE:VZ), ImmunoGen (NASDAQ:IMGN), Splunk (NASDAQ:SPLK), Government Properties Income Trust (NYSE:GOV), RadNet (NASDAQ:RDNT)
On Wednesday shares of Verizon Communications Inc. (NYSE:VZ) closed at $49.64. Company’s sales growth for last 5 years was 3.30% and EPS growth for next 5 years is recorded as 5.93%. Verizon Communications Inc. (NYSE:VZ) caught lying in effort to upgrade customers to more expensive broadband plans. The idea that an Internet service provider might…
-
Eye Catching Stocks: The Goodyear Tire & Rubber Company (NASDAQ:GT), ImmunoGen (NASDAQ:IMGN), Actinium Pharmaceuticals (NYSEMKT:ATNM), Nokia (NYSE:NOK), Ford Motor (NYSE:F)
On Wednesday shares of The Goodyear Tire & Rubber Company (NASDAQ:GT) closed at $28.34. Company’s sales growth for last 5 years was 2.20% and EPS growth for next 5 years is recorded as 11.00%. The Goodyear Tire & Rubber Co. (NASDAQ:GT) on Wednesday reported first-quarter net income of $224 million, after reporting a loss in…
-
Hot Stock List: ImmunoGen (NASDAQ:IMGN), QUALCOMM (NASDAQ:QCOM), Google Inc (NASDAQ:GOOGL), Citigroup Inc. (NYSE:C), Carlisle Companies Incorporated (NYSE:CSL)
On Thursday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $10.25. Company’s sales growth for last 5 years was 16.40%. ImmunoGen, Inc. (NASDAQ: IMGN), early in Phase I for head and neck with a cancer immunotherapy, has investors paying $10 per share with a market cap of $871 million. Transgene SA (TNG.PA:Paris) is enrolling for Phase…
-
Top Wall Street Stories: ImmunoGen (NASDAQ:IMGN), China Nepstar Chain Drugstore (NYSE:NPD), The Travelers Companies (NYSE:TRV), International Business Machines (NYSE:IBM), Entercom Communications (NYSE:ETM)
On Thursday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $9.83. Company’s sales growth for last 5 years was 16.40%. On April 3, 2015, ImmunoGen, Inc. (NASDAQ:IMGN) and a subsidiary completed the previously announced royalty transaction with Immunity Royalty Holdings, L.P. China Nepstar Chain Drugstore Ltd. (NYSE:NPD) in last trading activity increased 20.99% to close at…
-
Stock Highlights: Endocyte (NASDAQ:ECYT), ImmunoGen (NASDAQ:IMGN), Reinsurance Group of America Inc. (NYSE:RGA), Alexco Resource Corporation (NYSEMKT:AXU), Celgene Corporation (NASDAQ:CELG)
On Tuesday shares of Endocyte, Inc. (NASDAQ:ECYT) closed at $5.98. Company’s sales growth for last 5 years was 88.00%. Endocyte, Inc. (NASDAQ:ECYT) announced that data from the PROCEED Study presented at the 2015 Annual Meeting on Women’s Cancer in Chicago on Saturday, March 28 in Chicago. ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity increased 2.15%…
-
Today’s Hot List: Ariad Pharmaceuticals Inc. (NASDAQ:ARIA), ImmunoGen (NASDAQ:IMGN), UIL Holdings Corporation (NYSE:UIL), Colfax Corporation (NYSE:CFX), CME Group Inc. (NASDAQ:CME)
On Wednesday shares of Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) closed at $8.10. Company’s sales growth for last 5 years was 66.20% and EPS growth for next 5 years is recorded as 41.40%. Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) on March 19, 2015, released that it is schedule of preclinical data presentations to be made at the American Association…
-
Watch List: ImmunoGen (NASDAQ:IMGN), Philip Morris International (NYSE:PM), China Recycling Energy Corporation (NASDAQ:CREG), Flextronics International (NASDAQ:FLEX), Sonic Foundry (NASDAQ:SOFO)
On Tuesday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $8.95. Company’s sales growth for last 5 years was 16.40%. ImmunoGen Inc. (Nasdaq:IMGN) announced a $200 million non-dilutive royalty transaction with funds managed by TPG Special Situations Partners (“TSSP”). In return for the payment to ImmunoGen TSSP will have the right to receive 100% of the…
-
Active Stocks to Watch: ImmunoGen (NASDAQ:IMGN), Repligen Corporation (NASDAQ:RGEN), AT&T (NYSE:T), AeroVironment (NASDAQ:AVAV), TherapeuticsMD (NYSEMKT:TXMD)
On Friday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $8.25. Company’s sales growth for last 5 years was 16.40%.On March 20, 2015, ImmunoGen, Inc. (NASDAQ:IMGN) entered into a right-to-test agreement with Takeda Pharmaceutical Company Limited through its wholly owned subsidiary, Millennium Pharmaceuticals, Inc. The agreement provides Takeda with the right to (a) take exclusive options,…
-
Healthcare Gainers: Calithera Biosciences (NASDAQ:CALA), ImmunoGen (NASDAQ:IMGN), NephroGenex (NASDAQ:NRX), PhotoMedex (NASDAQ:PHMD), Kamada (NASDAQ:KMDA)
On Monday shares of Calithera Biosciences, Inc. (NASDAQ:CALA) closed at $18.74. Company’s EPS growth for next 5 years is recorded as 75.00%. Calithera Biosciences, Inc. (NASDAQ:CALA), announced that the Company’s fourth quarter and year-end 2014 financial results will be released on Thursday, March 26, 2015. ImmunoGen, Inc. (NASDAQ:IMGN) in last trading activity increased 16.80% to…
-
Shining on Major News: ImmunoGen (NASDAQ:IMGN), New Source Energy Partners L.P. (NYSE:NSLP), Citigroup Inc. (NYSE:C), Facebook Inc (NASDAQ:FB), Tenet Healthcare (NYSE:THC)
On Friday shares of ImmunoGen, Inc. (NASDAQ:IMGN) closed at $7.44. Company’s sales growth for last 5 years was 16.40%. ImmunoGen, Inc. (NASDAQ:IMGN) announced that Takeda has licensed exclusive rights to use ImmunoGen’s ADC technology – including ImmunoGen’s new DNA-acting IGN payload agents – to develop and commercialize targeted anticancer therapeutics to up to two undisclosed…